vs

Side-by-side financial comparison of Information Services Group Inc. (III) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

Information Services Group Inc. is the larger business by last-quarter revenue ($61.2M vs $57.3M, roughly 1.1× RHYTHM PHARMACEUTICALS, INC.). Information Services Group Inc. runs the higher net margin — 4.3% vs -83.0%, a 87.2% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 5.9%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -2.4%).

EBSCO Information Services, headquartered in Ipswich, Massachusetts, is a division of EBSCO Industries Inc., a private company headquartered in Birmingham, Alabama. EBSCO provides products and services to libraries of many types around the world. Its products include EBSCONET, a complete e-resource management system, and EBSCOhost, which supplies a fee-based online research service with 375 full-text databases, a collection of 600,000-plus ebooks, subject indexes, point-of-care medical refere...

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

III vs RYTM — Head-to-Head

Bigger by revenue
III
III
1.1× larger
III
$61.2M
$57.3M
RYTM
Growing faster (revenue YoY)
RYTM
RYTM
+30.9% gap
RYTM
36.9%
5.9%
III
Higher net margin
III
III
87.2% more per $
III
4.3%
-83.0%
RYTM
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
-2.4%
III

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
III
III
RYTM
RYTM
Revenue
$61.2M
$57.3M
Net Profit
$2.6M
$-47.5M
Gross Margin
44.8%
91.6%
Operating Margin
8.4%
-82.2%
Net Margin
4.3%
-83.0%
Revenue YoY
5.9%
36.9%
Net Profit YoY
-14.1%
-9.6%
EPS (diluted)
$0.06
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
III
III
RYTM
RYTM
Q4 25
$61.2M
$57.3M
Q3 25
$62.4M
$51.3M
Q2 25
$61.6M
$48.5M
Q1 25
$59.6M
$32.7M
Q4 24
$57.8M
$41.8M
Q3 24
$61.3M
$33.3M
Q2 24
$64.3M
$29.1M
Q1 24
$64.3M
$26.0M
Net Profit
III
III
RYTM
RYTM
Q4 25
$2.6M
$-47.5M
Q3 25
$3.1M
$-52.9M
Q2 25
$2.2M
$-46.6M
Q1 25
$1.5M
$-49.5M
Q4 24
$3.0M
$-43.3M
Q3 24
$1.1M
$-43.6M
Q2 24
$2.0M
$-32.3M
Q1 24
$-3.4M
$-141.4M
Gross Margin
III
III
RYTM
RYTM
Q4 25
44.8%
91.6%
Q3 25
42.2%
89.3%
Q2 25
42.2%
88.6%
Q1 25
43.1%
88.8%
Q4 24
41.5%
90.9%
Q3 24
40.4%
88.5%
Q2 24
39.5%
89.9%
Q1 24
36.1%
89.2%
Operating Margin
III
III
RYTM
RYTM
Q4 25
8.4%
-82.2%
Q3 25
7.4%
-102.6%
Q2 25
7.6%
-93.4%
Q1 25
5.7%
-143.7%
Q4 24
0.3%
-98.6%
Q3 24
7.0%
-132.0%
Q2 24
5.7%
-139.2%
Q1 24
-3.7%
-538.7%
Net Margin
III
III
RYTM
RYTM
Q4 25
4.3%
-83.0%
Q3 25
4.9%
-103.1%
Q2 25
3.5%
-96.1%
Q1 25
2.5%
-151.4%
Q4 24
5.3%
-103.6%
Q3 24
1.9%
-131.2%
Q2 24
3.2%
-110.9%
Q1 24
-5.3%
-544.4%
EPS (diluted)
III
III
RYTM
RYTM
Q4 25
$0.06
$-0.73
Q3 25
$0.06
$-0.82
Q2 25
$0.04
$-0.75
Q1 25
$0.03
$-0.81
Q4 24
$0.07
$-0.71
Q3 24
$0.02
$-0.73
Q2 24
$0.04
$-0.55
Q1 24
$-0.07
$-2.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
III
III
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$28.7M
$388.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$94.7M
$139.1M
Total Assets
$211.0M
$480.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
III
III
RYTM
RYTM
Q4 25
$28.7M
$388.9M
Q3 25
$28.7M
$416.1M
Q2 25
$25.2M
$291.0M
Q1 25
$20.1M
$314.5M
Q4 24
$23.1M
$320.6M
Q3 24
$9.7M
$298.4M
Q2 24
$11.8M
$319.1M
Q1 24
$14.0M
$201.2M
Stockholders' Equity
III
III
RYTM
RYTM
Q4 25
$94.7M
$139.1M
Q3 25
$94.7M
$148.8M
Q2 25
$94.1M
$-11.9M
Q1 25
$95.0M
$18.9M
Q4 24
$96.3M
$21.7M
Q3 24
$96.6M
$11.2M
Q2 24
$95.5M
$39.3M
Q1 24
$95.6M
$61.6M
Total Assets
III
III
RYTM
RYTM
Q4 25
$211.0M
$480.2M
Q3 25
$213.3M
$506.9M
Q2 25
$200.7M
$372.7M
Q1 25
$202.4M
$386.7M
Q4 24
$204.5M
$392.3M
Q3 24
$227.1M
$363.6M
Q2 24
$235.3M
$381.8M
Q1 24
$234.2M
$258.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
III
III
RYTM
RYTM
Operating Cash FlowLast quarter
$5.1M
$-25.4M
Free Cash FlowOCF − Capex
$4.3M
FCF MarginFCF / Revenue
7.0%
Capex IntensityCapex / Revenue
1.2%
Cash ConversionOCF / Net Profit
1.94×
TTM Free Cash FlowTrailing 4 quarters
$25.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
III
III
RYTM
RYTM
Q4 25
$5.1M
$-25.4M
Q3 25
$11.1M
$-26.6M
Q2 25
$11.9M
$-23.3M
Q1 25
$978.0K
$-40.4M
Q4 24
$6.6M
$-18.8M
Q3 24
$8.8M
$-25.2M
Q2 24
$2.2M
$-29.1M
Q1 24
$2.3M
$-40.7M
Free Cash Flow
III
III
RYTM
RYTM
Q4 25
$4.3M
Q3 25
$9.5M
Q2 25
$11.1M
Q1 25
$141.0K
Q4 24
$6.0M
Q3 24
$8.4M
Q2 24
$1.3M
Q1 24
$1.3M
FCF Margin
III
III
RYTM
RYTM
Q4 25
7.0%
Q3 25
15.2%
Q2 25
18.0%
Q1 25
0.2%
Q4 24
10.4%
Q3 24
13.7%
Q2 24
2.0%
Q1 24
2.0%
Capex Intensity
III
III
RYTM
RYTM
Q4 25
1.2%
Q3 25
2.5%
Q2 25
1.4%
Q1 25
1.4%
Q4 24
0.9%
Q3 24
0.6%
Q2 24
1.4%
Q1 24
1.6%
Cash Conversion
III
III
RYTM
RYTM
Q4 25
1.94×
Q3 25
3.62×
Q2 25
5.46×
Q1 25
0.66×
Q4 24
2.15×
Q3 24
7.66×
Q2 24
1.07×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons